Ondokuz Mayis University Samsun School of Nursing, Samsun, Turkey.
Burns. 2012 Sep;38(6):813-9. doi: 10.1016/j.burns.2012.03.011. Epub 2012 Jun 9.
Burns are common injuries that cause problems to societies throughout the world. In order to reduce the cost of burn treatment in children, it is extremely important to determine the burn epidemiology and the cost of medicines used in burn treatment. The present study used a retrospective design, with data collected from medical records of 140 paediatric patients admitted to a burn centre between 1 January 2009 and 31 December 2009. Medical records were examined to determine burn epidemiology, medication administered, dosage, and duration of use. Descriptive statistical analysis was completed for all variables; chi-square was used to examine the relationship between certain variables. It was found that 62.7% of paediatric burns occur in the kitchen, with 70.7% involving boiling water; 55.7% of cases resulted in third-degree burns, 19.3% required grafting, and mean duration of hospital stay was 27.5 ± 1.2 days. Medication costs varied between $1.38 US dollars (USD) and $14,159.09, total drug cost was $46,148.03 and average cost per patient was $329.63. In this study, the medication cost for burn patients was found to be relatively high, with antibiotics comprising the vast majority of medication expenditure. Most paediatric burns are preventable, so it is vital to educate families about potential household hazards that can be addressed to reduce the risk of a burn. Programmes are also recommended to reduce costs and the inappropriate prescribing of medication.
烧伤是一种常见的损伤,会给全世界的社会带来问题。为了降低儿童烧伤治疗的成本,确定烧伤流行病学和烧伤治疗中使用的药物成本非常重要。本研究采用回顾性设计,从 2009 年 1 月 1 日至 12 月 31 日期间在烧伤中心收治的 140 名儿科患者的病历中收集数据。检查病历以确定烧伤流行病学、使用的药物、剂量和使用时间。对所有变量进行描述性统计分析;卡方检验用于检验某些变量之间的关系。结果发现,62.7%的儿科烧伤发生在厨房,70.7%涉及沸水;55.7%的病例为三度烧伤,19.3%需要植皮,平均住院时间为 27.5±1.2 天。药物费用在 1.38 美元至 14159.09 美元之间,总药物费用为 46148.03 美元,每位患者的平均费用为 329.63 美元。在这项研究中,烧伤患者的药物费用相对较高,抗生素占药物支出的绝大部分。大多数儿科烧伤是可以预防的,因此,教育家庭了解可能存在的家庭危险,以降低烧伤风险至关重要。还建议开展方案以降低成本和药物的不当使用。